Zobrazeno 1 - 10
of 21
pro vyhledávání: '"CHRISTOS VALLILAS"'
Autor:
Dimitra Galiti, Helena Linardou, Sofia Agelaki, Athanasios Karampeazis, Nikolaos Tsoukalas, Amanda Psyrri, Michalis Karamouzis, Konstantinos N. Syrigos, Alexandros Ardavanis, Ilias Athanasiadis, Eleni Arvanitou, Stavroula Sgourou, Anastasia Mala, Christos Vallilas, Ioannis Boukovinas
Publikováno v:
Current Oncology, Vol 30, Iss 8, Pp 7608-7619 (2023)
Introduction: The increasing burden of cancer, the development of novel therapies, and the COVID-19 pandemic have made cancer care more complex. Digital innovation was then pushed toward developing platforms to facilitate access to cancer care. Age,
Externí odkaz:
https://doaj.org/article/00acd5ac1cd74c8bb41c30f3c9c61714
Autor:
Stavros P. Papadakos, Konstantinos Arvanitakis, Ioanna E. Stergiou, Christos Vallilas, Stavros Sougioultzis, Georgios Germanidis, Stamatios Theocharis
Publikováno v:
Pharmaceutics, Vol 15, Iss 10, p 2460 (2023)
Hepatocellular carcinoma (HCC) stands as a significant contributor to global cancer-related mortality. Chronic inflammation, often arising from diverse sources such as viral hepatitis, alcohol misuse, nonalcoholic fatty liver disease (NAFLD), and non
Externí odkaz:
https://doaj.org/article/c1c0af4022f04690add251f0fe58ffdc
Autor:
Anna Koumarianou, Anastasios Ntavatzikos, David Symeonidis, Christos Vallilas, Maria Giannakakou, Georgios Papaxoinis, Spyridon Xynogalos, Ioannis Boukovinas, Stamatina Demiri, Katerina Kampoli, Georgios Oikonomopoulos, Epaminontas Samantas, Eleni Res, Nikolaos Androulakis, Georgia Vourli, Ioannis Souglakos, Michalis Karamouzis
Publikováno v:
Biomedicines, Vol 11, Iss 5, p 1267 (2023)
Background: Trifluridine/tipiracil (FTD/TPI) is an oral antimetabolite agent comprised of trifluridine, a thymidine-based nucleoside analogue that inhibits cell proliferation following its incorporation into DNA, and tipiracil that helps maintain the
Externí odkaz:
https://doaj.org/article/127365e0afa7497098993b8317173877
Autor:
Theodoros Androutsakos, Athanasios-Dimitrios Bakasis, Abraham Pouliakis, Maria Gazouli, Christos Vallilas, Gregorios Hatzis
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 16, p 9430 (2022)
Hepatocellular carcinoma (HCC) is the most common primary liver tumor leading to significant morbidity and mortality; its exact genetic background is largely unrecognized. Toll-like receptor-4 (TLR4) reacts with lipopolysaccharides, molecules found i
Externí odkaz:
https://doaj.org/article/6951de16994c47a693d6787c63556837
Autor:
Evangelos Koustas, Eleni-Myrto Trifylli, Panagiotis Sarantis, Nikolaos I. Kontolatis, Christos Damaskos, Nikolaos Garmpis, Christos Vallilas, Anna Garmpi, Athanasios G. Papavassiliou, Michalis V. Karamouzis
Publikováno v:
Life, Vol 11, Iss 12, p 1304 (2021)
Gastric cancer is the fifth most common malignancy and the third leading cause of cancer-related death worldwide. The three entirely variable entities have distinct epidemiology, molecular characteristics, prognosis, and strategies for clinical manag
Externí odkaz:
https://doaj.org/article/4e6fecf5634e4172a84cc89b83c0e283
Autor:
Christos Vallilas, Panagiotis Sarantis, Anastasios Kyriazoglou, Evangelos Koustas, Stamatios Theocharis, Athanasios G. Papavassiliou, Michalis V. Karamouzis
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 2, p 493 (2021)
Gastrointestinal stromal tumors (GISTs) are the most common types of malignant mesenchymal tumors in the gastrointestinal tract, with an estimated incidence of 1.5/100.000 per year and 1–2% of gastrointestinal neoplasms. About 75–80% of patients
Externí odkaz:
https://doaj.org/article/e432fecb611a4b28924f2351f7c4cc6f
Autor:
Nikolaos Garmpis, Konstantinos Kontzoglou, Christos Vallilas, Evangelos Koustas, Panagiotis Sarantis, Christos Damaskos, Nikolaos Trakas, Vasiliki E Georgakopoulou, Dimitrios Schizas, Athanasios Syllaios, Dimitrios Dimitroulis, Anna Garmpi, Alexandros Patsouras, Afroditi Nonni, Efstathios Antoniou
Publikováno v:
Current Medicinal Chemistry. 29:2979-2994
Abstract: Colorectal cancer (CRC) comprises a heterogeneous group of gastrointestinal tract tumors. It is a multifactorial disease, and a plethora of distinct factors are involved in its pathogenesis and pathophysiology. The development of CRC is not
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62574f01acf29f4fdbfa291e725e238f
https://doi.org/10.2174/0929867328666210915105929
https://doi.org/10.2174/0929867328666210915105929
Autor:
NIKOLAOS GARMPIS, CHRISTOS DAMASKOS, DIMITRIOS DIMITROULIS, ANNA GARMPI, EVANGELOS DIAMANTIS, PANAGIOTIS SARANTIS, VASILIKI E. GEORGAKOPOULOU, ALEXANDROS PATSOURAS, DIONYSIOS PREVEZANOS, ATHANASIOS SYLLAIOS, GEORGIOS KYRIAKOS, EVANGELOS KOUSTAS, MARKOS DESPOTIDIS, CHRISTOS VALLILAS, PETROS PAPALEXIS, EFSTATHIOS A. ANTONIOU, KONSTANTINOS KONTZOGLOU, GREGORY KOURAKLIS
Publikováno v:
In Vivo
Pancreatic cancer is one of the most fatal malignancies, and therefore, new strategies, which aim at the improvement of the prognosis of this lethal disease, are needed. Many clinical trials have failed to improve overall survival. Nowadays, research
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3e1a7c7988f0c2a3d1639266a893cdc
https://doi.org/10.21873/invivo.12736
https://doi.org/10.21873/invivo.12736
Autor:
Dimitra Galiti, Helena Linardou, Sofia Agelaki, Athanasios Karampeazis, Nikolaos Tsoukalas, Amanda Psyrri, Michalis Karamouzis, Konstantinos Syrigos, Alexandros Ardavanis, Ilias Athanasiadis, Eleni Arvanitou, Stavroula Sgourou, Vasileios Kouloulias, Anastasia Mala, Christos Vallilas, Ioannis Boukovinas
Background: Globally 43.8 million people live with cancer. A 60% increase of cancer cases is estimated by 2040, with 29.4 million patients per year requiring therapy. Optimization of cancer management, using digital innovation, is urgently needed. Cu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bca1b7ed7d2918d13a4ed2c45db0a356
https://doi.org/10.21203/rs.3.rs-1015730/v1
https://doi.org/10.21203/rs.3.rs-1015730/v1
Autor:
Athanasios G. Papavassiliou, Nikolaos I. Kontolatis, Nikolaos Garmpis, Evangelos Koustas, Panagiotis Sarantis, Michalis V. Karamouzis, Eleni-Myrto Trifylli, Anna Garmpi, Christos Damaskos, Christos Vallilas
Publikováno v:
Life
Life, Vol 11, Iss 1304, p 1304 (2021)
Life, Vol 11, Iss 1304, p 1304 (2021)
Gastric cancer is the fifth most common malignancy and the third leading cause of cancer-related death worldwide. The three entirely variable entities have distinct epidemiology, molecular characteristics, prognosis, and strategies for clinical manag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e16241f6fa0948206b0e759b20d2fd4
https://pubmed.ncbi.nlm.nih.gov/34947835
https://pubmed.ncbi.nlm.nih.gov/34947835